🧬MedTech & GLP-1Thematic Leadership

Healthcare Innovators & GLP-1

GLP-1 metabolic therapeutics, robotic surgery platforms, targeted oncology, and biopharma innovators.

Selection Criteria & Quantitative Methodology
Analyzes commercial pipeline exclusivity, patent runways, FDA regulatory approvals, and operating cash conversion.
Showing top institutional securities in this universe. Click any ticker to view complete quotes and forensic factor cards.
Customize Filters in Screener →
#SymbolCompany NameSectorQuant StanceAnalysis
1LLYEli Lilly and CompanyHealth CareQuant ConvictionResearch
2NVONVO CorporationConsumer DiscretionaryQuant ConvictionResearch
3ISRGISRG CorporationConsumer DiscretionaryQuant ConvictionResearch
4VRTXVRTX CorporationConsumer DiscretionaryQuant ConvictionResearch
5REGNREGN CorporationHealth CareQuant ConvictionResearch
6BNTXBNTX CorporationConsumer DiscretionaryQuant ConvictionResearch
7MRNAMRNA CorporationConsumer DiscretionaryQuant ConvictionResearch
Vantage PRO Institutional Intelligence

Upgrade to Vantage Pro — Unlock Full 2,714 Stock Quant Screener

Gain instant access to all 10 securities in the Healthcare Innovators & GLP-1, complete with live quantitative factor ranks (#1 to #2,714), Piotroski F-Score forensic accounting shields, and full financial statement drill-downs.

Real-time authentic 4-Factor rankings
Forensic Value Trap Shields (Altman Z & Beneish M)
Full 2,714-stock systematic screener
Unlimited 1-click CSV & Excel downloads

Explore More Curated Stock Lists